Risk factors and outcomes of acute kidney injury in South African critically ill adults: a prospective cohort study.


Journal

BMC nephrology
ISSN: 1471-2369
Titre abrégé: BMC Nephrol
Pays: England
ID NLM: 100967793

Informations de publication

Date de publication:
10 12 2019
Historique:
received: 15 05 2019
accepted: 08 11 2019
entrez: 12 12 2019
pubmed: 12 12 2019
medline: 5 11 2020
Statut: epublish

Résumé

There is a marked paucity of data concerning AKI in Sub-Saharan Africa, where there is a substantial burden of trauma and HIV. Prospective data was collected on all patients admitted to a multi-disciplinary ICU in South Africa during 2017. Development of AKI (before or during ICU admission) was recorded and renal recovery 90 days after ICU discharge was determined. Of 849 admissions, the mean age was 42.5 years and mean SAPS 3 score was 48.1. Comorbidities included hypertension (30.5%), HIV (32.6%), diabetes (13.3%), CKD (7.8%) and active tuberculosis (6.2%). The most common reason for admission was trauma (26%). AKI developed in 497 (58.5%). Male gender, illness severity, length of stay, vasopressor drugs and sepsis were independently associated with AKI. AKI was associated with a higher in-hospital mortality rate of 31.8% vs 7.23% in those without AKI. Age, active tuberculosis, higher SAPS 3 score, mechanical ventilation, vasopressor support and sepsis were associated with an increased adjusted odds ratio for death. HIV was not independently associated with AKI or hospital mortality. CKD developed in 14 of 110 (12.7%) patients with stage 3 AKI; none were dialysis-dependent. In this large prospective multidisciplinary ICU cohort of younger patients, AKI was common, often associated with trauma in addition to traditional risk factors and was associated with good functional renal recovery at 90 days in most survivors. Although the HIV prevalence was high and associated with higher mortality, this was related to the severity of illness and not to HIV status per se.

Sections du résumé

BACKGROUND
There is a marked paucity of data concerning AKI in Sub-Saharan Africa, where there is a substantial burden of trauma and HIV.
METHODS
Prospective data was collected on all patients admitted to a multi-disciplinary ICU in South Africa during 2017. Development of AKI (before or during ICU admission) was recorded and renal recovery 90 days after ICU discharge was determined.
RESULTS
Of 849 admissions, the mean age was 42.5 years and mean SAPS 3 score was 48.1. Comorbidities included hypertension (30.5%), HIV (32.6%), diabetes (13.3%), CKD (7.8%) and active tuberculosis (6.2%). The most common reason for admission was trauma (26%). AKI developed in 497 (58.5%). Male gender, illness severity, length of stay, vasopressor drugs and sepsis were independently associated with AKI. AKI was associated with a higher in-hospital mortality rate of 31.8% vs 7.23% in those without AKI. Age, active tuberculosis, higher SAPS 3 score, mechanical ventilation, vasopressor support and sepsis were associated with an increased adjusted odds ratio for death. HIV was not independently associated with AKI or hospital mortality. CKD developed in 14 of 110 (12.7%) patients with stage 3 AKI; none were dialysis-dependent.
CONCLUSIONS
In this large prospective multidisciplinary ICU cohort of younger patients, AKI was common, often associated with trauma in addition to traditional risk factors and was associated with good functional renal recovery at 90 days in most survivors. Although the HIV prevalence was high and associated with higher mortality, this was related to the severity of illness and not to HIV status per se.

Identifiants

pubmed: 31822290
doi: 10.1186/s12882-019-1620-7
pii: 10.1186/s12882-019-1620-7
pmc: PMC6902455
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

460

Références

Clin J Am Soc Nephrol. 2014 Jan;9(1):12-20
pubmed: 24178971
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Lancet. 2015 Jun 27;385(9987):2616-43
pubmed: 25777661
Intensive Care Med. 2009 Nov;35(11):1907-15
pubmed: 19693486
Kidney Int. 2010 Dec;78(11):1171-7
pubmed: 20811330
BMC Nephrol. 2015 Jan 16;16:4
pubmed: 25592556
Am J Respir Crit Care Med. 2014 May 1;189(9):1075-81
pubmed: 24601781
Lancet Infect Dis. 2015 Sep;15(9):1066-1076
pubmed: 26112077
N Engl J Med. 2008 Jul 3;359(1):7-20
pubmed: 18492867
Nephrology (Carlton). 2011 Jan;16(1):39-44
pubmed: 21175975
Nephron. 2015;131(2):107-12
pubmed: 26332325
Intensive Care Med. 2015 Aug;41(8):1411-23
pubmed: 26162677
N Engl J Med. 2014 Oct 2;371(14):1344-53
pubmed: 25265493
BMC Nephrol. 2016 Aug 24;17(1):118
pubmed: 27557748
N Engl J Med. 2014 Jul 3;371(1):58-66
pubmed: 24988558
Lancet. 2013 Jul 13;382(9887):170-9
pubmed: 23727171
BMC Nephrol. 2017 Feb 20;18(1):70
pubmed: 28219327
N Engl J Med. 2009 Oct 22;361(17):1627-38
pubmed: 19846848
Nat Rev Nephrol. 2013 Oct;9(10):610-22
pubmed: 23958719
S Afr Med J. 2016 Jan 21;106(2):156-9
pubmed: 26821893
S Afr Med J. 2019 Aug 22;109(8b):630-642
pubmed: 31456541
S Afr Med J. 2017 Sep 22;107(10):877-881
pubmed: 29022532
Intensive Care Med. 2005 Oct;31(10):1345-55
pubmed: 16132892
JAMA. 2016 Feb 23;315(8):775-87
pubmed: 26903336
PLoS One. 2017 Jun 1;12(6):e0177460
pubmed: 28570592
Clin Chest Med. 2009 Dec;30(4):797-810, x
pubmed: 19925968
Int J STD AIDS. 2015 Nov;26(13):915-21
pubmed: 25411349
Am J Kidney Dis. 2013 May;61(5):649-72
pubmed: 23499048
Sci Rep. 2017 Dec 7;7(1):17163
pubmed: 29215080
Intensive Care Med. 2017 Sep;43(9):1198-1209
pubmed: 28138736
S Afr Med J. 2009 Dec 07;99(12):873-5
pubmed: 20459997
Kidney Int. 2013 Sep;84(3):457-67
pubmed: 23636171
Biomed Res Int. 2016;2016:2015251
pubmed: 27042657
Rev Inst Med Trop Sao Paulo. 2016 Jul 11;58:52
pubmed: 27410912
Nat Clin Pract Nephrol. 2008 Dec;4(12):664-71
pubmed: 18838981
Clin Kidney J. 2013 Dec;6(6):584-9
pubmed: 26069826
Ann Surg. 2015 Jun;261(6):1207-14
pubmed: 24887982
Intensive Care Med. 1996 Jul;22(7):707-10
pubmed: 8844239
J Int Assoc Physicians AIDS Care (Chic). 2008 Jul-Aug;7(4):178-81
pubmed: 18626122
Crit Care. 2013 Jul 22;17(4):R145
pubmed: 23876346
Nat Clin Pract Nephrol. 2008 Mar;4(3):138-53
pubmed: 18212780
Semin Nephrol. 2008 Jul;28(4):348-53
pubmed: 18620957
Intensive Care Med. 2016 Feb;42(2):137-46
pubmed: 26626062
J Surg Res. 2018 Dec;232:376-382
pubmed: 30463744

Auteurs

Ryan E Aylward (RE)

Adult Critical Care Unit, Livingstone Hospital, Port Elizabeth, South Africa. ryaylion@gmail.com.

Elizabeth van der Merwe (E)

Adult Critical Care Unit, Livingstone Hospital, Port Elizabeth, South Africa.
Walter Sisulu University, Mthatha, South Africa.

Sisa Pazi (S)

Department of Statistics, Nelson Mandela University, Port Elizabeth, South Africa.

Minette van Niekerk (M)

Adult Critical Care Unit, Livingstone Hospital, Port Elizabeth, South Africa.

Jason Ensor (J)

Division of Nephrology and Hypertension, Livingstone Hospital, Port Elizabeth, South Africa.
Department of Medicine, Division Nephrology and Hypertension, University of Cape Town, Cape Town, South Africa.

Debbie Baker (D)

Adult Critical Care Unit, Livingstone Hospital, Port Elizabeth, South Africa.
Walter Sisulu University, Mthatha, South Africa.

Robert J Freercks (RJ)

Division of Nephrology and Hypertension, Livingstone Hospital, Port Elizabeth, South Africa.
Department of Medicine, Division Nephrology and Hypertension, University of Cape Town, Cape Town, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH